Drug intelligence / Profile preview

molybdenum

Development stage
Phase 2
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous
01

Overview

Molybdenum is an essential trace mineral and chemical element (atomic number 42, symbol Mo) required for human health. It acts as a cofactor in several key enzymes, including sulfite oxidase, xanthine oxidase, aldehyde oxidase, and mitochondrial amidoxime reducing component (mARC), which are involved in the metabolism of sulfur-containing amino acids, purines, pyrimidines, drugs, and toxins. Molybdenum deficiency is extremely rare but can be treated or prevented with supplementation. It is available as a dietary supplement and under the brand name Molypen for clinical use to address deficiency states[1][2][3][4]. Molybdenum is also used industrially in metallurgy and catalysis but its pharmaceutical use centers on nutritional supplementation.

Brand names
Molypen
Other names
Mo
02

Targets

SUOX (Sulfite oxidase)AOX1 (Aldehyde oxidase 1)MTARC1 (Mitochondrial amidoxime-reducing component 1)XO (Xanthine Oxidoreductase)

Beyond the preview

Go deeper on molybdenum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on molybdenum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call